Masimo Corporation (LON:0JZ2)
London · Delayed Price · Currency is GBP · Price in USD 145.96
-1.85 (-1.25%)
At close: Oct 17, 2025
Masimo Market Cap
Masimo has a market cap or net worth of 5.95 billion as of October 17, 2025. Its market cap has increased by 8.95% in one year.
Market Cap
5.95B
Enterprise Value
6.32B
Revenue
1.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
145.96
Market Cap Chart
Since August 8, 2007, Masimo's market cap has increased from 541.95M to 5.95B, an increase of 998.49%. That is a compound annual growth rate of 14.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 5.95B | -15.79% |
| Dec 31, 2024 | 7.07B | 45.39% |
| Dec 29, 2023 | 4.86B | -24.67% |
| Dec 30, 2022 | 6.45B | -45.94% |
| Dec 31, 2021 | 11.94B | 10.33% |
| Dec 31, 2020 | 10.82B | 69.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.74B |
| GSK plc | 65.34B |
| Haleon | 31.33B |
| Smith & Nephew | 11.41B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 3.93B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.82B |